A Robust, Automated Karl Fischer Titration System - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

A Robust, Automated Karl Fischer Titration System
The authors developed a robust, automated system to conduct Karl Fischer moisture assays for lyophilized products.


Pharmaceutical Technology
Volume 33, Issue 11, pp. 52-60

Conclusion

The authors have demonstrated a system that can perform Karl Fischer titration unattended. This instrument is fully validated for use in activities such as lyophilization-cycle development, technology transfer between various manufacturing sites, and manufacturing-discrepancy investigations.

Although the platform upon which this system is based is highly customizable and versatile, the authors decided to sacrifice functionality in favor of robustness. As a result, this instrument requires minimal training for operator proficiency, requires little maintenance, and has seen heavy use. Overall, the instrument it has been a cost-effective tool that saved labor, time, and money.

Acknowledgments

The authors would like to thank M. Joyce, D. Lawrence, D. Mehrwein, C. Buruel, K. Kifle, A. Gonzales, and P. Hearne for suggestions and help with system validation.

Philippe Lam* is a senior engineer for pharmaceutical process research and development at Genentech, 1 DNA Way, South San Francisco, CA 94080, tel. 650.225.7002, fax 650.225.3616,
. Mike Nariman is a senior systems architect at AB Controls.

*To whom all correspondence should be addressed.

Submitted: Dec. 4, 2008. Accepted: Feb. 19, 2009.




What would you do differently? Submit your comments about this paper in the space below.

References

1. FDA, Guideline for the Determination of Residual Moisture in Dried Biological Products (Rockville, MD, Jan. 1990).

2. E. Scholz, Karl Fischer Titration, (Springer-Verlag, Berlin, 1984).

3. Mettler–Toledo, "Fundamentals of the Volumetric Karl Fischer Titration," (Mettler–Toledo, Columbus, OH, 1999), p. 42.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Source: Pharmaceutical Technology,
Click here